{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:17:26Z","timestamp":1793755046574,"version":"4.6.1"},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Various nanoparticle-based drug delivery systems for the treatment of neurological disorders have been widely studied. However, their inability to cross the blood\u2013brain barrier hampers the clinical translation of these therapeutic strategies. Liposomes are nanoparticles composed of lipid bilayers, which can effectively encapsulate drugs and improve drug delivery across the blood\u2013brain barrier and into brain tissue through their targeting and permeability. Therefore, they can potentially treat traumatic and nontraumatic central nervous system diseases. In this review, we outlined the common properties and preparation methods of liposomes, including thin-film hydration, reverse-phase evaporation, solvent injection techniques, detergent removal methods, and microfluidics techniques. Afterwards, we comprehensively discussed the current applications of liposomes in central nervous system diseases, such as Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, and brain tumors. Most studies related to liposomes are still in the laboratory stage and have not yet entered clinical trials. Additionally, their application as drug delivery systems in clinical practice faces challenges such as drug stability, targeting efficiency, and safety. Therefore, we proposed development strategies related to liposomes to further promote their development in neurological disease research.<\/jats:p>","DOI":"10.4103\/nrr.nrr-d-24-00048","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:15:50Z","timestamp":1725966950000},"page":"1883-1899","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety"],"prefix":"10.4103","volume":"20","author":[{"given":"Mingyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renrui","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-9095","authenticated-orcid":false,"given":"Wenqi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8053-9934","authenticated-orcid":false,"given":"Wanguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4652-5561","authenticated-orcid":false,"given":"Rui","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"R1-20260426","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"R2-20260426","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJN.S288236","article-title":"Engineered nanomaterials: the challenges and opportunities for nanomedicines","volume":"16","author":"Albalawi","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"R3-20260426","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.2042-7158.2010.01090.x","article-title":"Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent","volume":"62","author":"Ali","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"R4-20260426","doi-asserted-by":"crossref","first-page":"114503","DOI":"10.1016\/j.addr.2022.114503","article-title":"Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR","volume":"189","author":"Amin","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R5-20260426","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cis.2019.01.003","article-title":"Magnetic nanocarriers: evolution of spinel ferrites for medical applications","volume":"265","author":"Amiri","year":"2019","journal-title":"Adv Colloid Interface Sci"},{"key":"R6-20260426","doi-asserted-by":"crossref","first-page":"e0183506","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Ara\u00fajo","year":"2017","journal-title":"PLoS One"},{"key":"R7-20260426","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood-brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2021","journal-title":"Mol Pharm"},{"key":"R8-20260426","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R9-20260426","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.stemcr.2021.01.019","article-title":"Adult hippocampal neurogenesis in aging and Alzheimer\u2019s disease","volume":"16","author":"Babcock","year":"2021","journal-title":"Stem Cell Reports"},{"key":"R10-20260426","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jconrel.2023.11.002","article-title":"Astrocytes and microglia-targeted Danshensu liposomes enhance the therapeutic effects on cerebral ischemia-reperfusion injury","volume":"364","author":"Bai","year":"2023","journal-title":"J Control Release"},{"key":"R11-20260426","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/2081295a0","article-title":"Cation permeability of phospholipid model membranes: effect of narcotics","volume":"208","author":"Bangham","year":"1965","journal-title":"Nature"},{"key":"R12-20260426","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"R13-20260426","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"R14-20260426","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0005-2736(73)90408-2","article-title":"Single bilayer liposomes prepared without sonication","volume":"298","author":"Batzri","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"R15-20260426","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"R16-20260426","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jconrel.2021.09.010","article-title":"Increasing phagocytosis of microglia by targeting CD33 with liposomes displaying glycan ligands","volume":"338","author":"Bhattacherjee","year":"2021","journal-title":"J Control Release"},{"key":"R17-20260426","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"R18-20260426","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0005-2736(90)90440-Y","article-title":"Liposomes for the sustained drug release in vivo","volume":"1029","author":"Blume","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"R19-20260426","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40199-020-00340-1","article-title":"The effect of ethanol evaporation on the properties of inkjet produced liposomes","volume":"28","author":"Bnyan","year":"2020","journal-title":"Daru"},{"key":"R20-20260426","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"R21-20260426","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0005-2736(76)90308-4","article-title":"Single bilayer vesicles prepared without sonication. Physico-chemical properties","volume":"455","author":"Brunner","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"R22-20260426","doi-asserted-by":"crossref","first-page":"577633","DOI":"10.1016\/j.jneuroim.2021.577633","article-title":"The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma","volume":"357","author":"Chaudhary","year":"2021","journal-title":"J Neuroimmunol"},{"key":"R23-20260426","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/1673-5374.379042","article-title":"A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson\u2019s disease","volume":"19","author":"Chen","year":"2024","journal-title":"Neural Regen Res"},{"key":"R24-20260426","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2015.10.021","article-title":"Transferrin-modified liposome promotes \u03b1-mangostin to penetrate the blood-brain barrier","volume":"12","author":"Chen","year":"2016","journal-title":"Nanomedicine"},{"key":"R25-20260426","article-title":"Liposomes (a review), part one: manufacturing issues","author":"Chrai","year":"2001"},{"key":"R26-20260426","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1021\/la034311+","article-title":"From vesicle size distributions to bilayer elasticity via cryo-transmission and freeze-fracture electron microscopy","volume":"19","author":"Coldren","year":"2003","journal-title":"Langmuir"},{"key":"R27-20260426","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","article-title":"Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis","volume":"295","author":"Costa","year":"2019","journal-title":"J Control Release"},{"key":"R28-20260426","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R29-20260426","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"R30-20260426","doi-asserted-by":"crossref","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R31-20260426","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/pharmaceutics15010207","article-title":"Recent advances in intranasal liposomes for drug, gene, and vaccine delivery","volume":"15","author":"Duong","year":"2023","journal-title":"Pharmaceutics"},{"key":"R32-20260426","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-019-02000-4","article-title":"Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease","volume":"138","author":"Estus","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R33-20260426","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/brain\/awab416","article-title":"Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity","volume":"145","author":"Ezer","year":"2022","journal-title":"Brain"},{"key":"R34-20260426","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2017.07.004","article-title":"Ultrasound targeted CNS gene delivery for Parkinson\u2019s disease treatment","volume":"261","author":"Fan","year":"2017","journal-title":"J Control Release"},{"key":"R35-20260426","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol"},{"key":"R36-20260426","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"R37-20260426","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm Res"},{"key":"R38-20260426","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/ana.410440718","article-title":"Neuroprotective and neurorestorative properties of GDNF","volume":"44","author":"Gash","year":"1998","journal-title":"Ann Neurol"},{"key":"R39-20260426","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.3390\/ijms21249542","article-title":"Solid lipid curcumin particles protect medium spiny neuronal morphology, and reduce learning and memory deficits in the YAC128 mouse model of Huntington\u2019s disease","volume":"21","author":"Gharaibeh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R40-20260426","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"R41-20260426","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4103\/1673-5374.380875","article-title":"Olfactory dysfunction and its related molecular mechanisms in Parkinson\u2019s disease","volume":"19","author":"Gu","year":"2024","journal-title":"Neural Regen Res"},{"key":"R42-20260426","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"R43-20260426","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R44-20260426","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2015.1.FOCUS14767","article-title":"Novel delivery methods bypassing the blood-brain and blood-tumor barriers","volume":"38","author":"Hendricks","year":"2015","journal-title":"Neurosurg Focus"},{"key":"R45-20260426","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.procbio.2021.11.025","article-title":"Numerous nanoparticles as drug delivery system to control secondary immune response and promote spinal cord injury regeneration","volume":"112","author":"Hong","year":"2022","journal-title":"Process Biochem"},{"key":"R46-20260426","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol Rev"},{"key":"R47-20260426","doi-asserted-by":"crossref","first-page":"104948","DOI":"10.1016\/j.chemphyslip.2020.104948","article-title":"Effects of lipid composition in cationic liposomes on suppression of mast cell activation","volume":"231","author":"Inoh","year":"2020","journal-title":"Chem Phys Lipids"},{"key":"R48-20260426","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1021\/ja0318030","article-title":"Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing","volume":"126","author":"Jahn","year":"2004","journal-title":"J Am Chem Soc"},{"key":"R49-20260426","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1021\/la070051a","article-title":"Microfluidic directed formation of liposomes of controlled size","volume":"23","author":"Jahn","year":"2007","journal-title":"Langmuir"},{"key":"R50-20260426","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/21691401.2018.1561457","article-title":"In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery","volume":"47","author":"Jain","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"R51-20260426","doi-asserted-by":"crossref","first-page":"e115140","DOI":"10.1371\/journal.pone.0115140","article-title":"TAM receptors support neural stem cell survival, proliferation and neuronal differentiation","volume":"9","author":"Ji","year":"2014","journal-title":"PLoS One"},{"key":"R52-20260426","doi-asserted-by":"crossref","first-page":"e2200302","DOI":"10.1002\/smll.202200302","article-title":"Size-selective transfer of lipid nanoparticle-based drug carriers across the blood brain barrier via vascular occlusions following traumatic brain injury","volume":"18","author":"Khalin","year":"2022","journal-title":"Small"},{"key":"R53-20260426","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1471-4914(01)02246-8","article-title":"Alzheimer\u2019s and Parkinson\u2019s disease--overlapping or synergistic pathologies?","volume":"8","author":"Kurosinski","year":"2002","journal-title":"Trends Mol Med"},{"key":"R54-20260426","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2019.07.039","article-title":"A review of the molecular mechanisms of traumatic brain injury","volume":"131","author":"Ladak","year":"2019","journal-title":"World Neurosurg"},{"key":"R55-20260426","doi-asserted-by":"crossref","first-page":"43341","DOI":"10.1021\/acsami.0c13504","article-title":"Molecular design of layer-by-layer functionalized liposomes for oral drug delivery","volume":"12","author":"Lai","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"R56-20260426","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2018.09.047","article-title":"Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model","volume":"173","author":"Lakkadwala","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"key":"R57-20260426","doi-asserted-by":"crossref","first-page":"e2211420","DOI":"10.1002\/adma.202211420","article-title":"Optimizing lipid nanoparticles for delivery in primates","volume":"35","author":"Lam","year":"2023","journal-title":"Adv Mater"},{"key":"R58-20260426","doi-asserted-by":"crossref","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"R59-20260426","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2020.0299","article-title":"Huntingtin-lowering therapies for Huntington disease: a review of the evidence of potential benefits and risks","volume":"77","author":"Leavitt","year":"2020","journal-title":"JAMA Neurol"},{"key":"R60-20260426","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2012.01.026","article-title":"Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis","volume":"418","author":"Lee","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R61-20260426","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/pharmaceutics12030264","article-title":"Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches","volume":"12","author":"Lee","year":"2020","journal-title":"Pharmaceutics"},{"key":"R62-20260426","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","article-title":"Failure of neuronal maturation in Alzheimer disease dentate gyrus","volume":"67","author":"Li","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"R63-20260426","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biomaterials.2018.08.037","article-title":"A collagen microchannel scaffold carrying paclitaxel-liposomes induces neuronal differentiation of neural stem cells through Wnt\/\u03b2-catenin signaling for spinal cord injury repair","volume":"183","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"R64-20260426","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1038\/s41467-023-41946-8","article-title":"Aromatized liposomes for sustained drug delivery","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"R65-20260426","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jconrel.2020.02.044","article-title":"Ultrasound-responsive neurotrophic factor-loaded microbubble-liposome complex: preclinical investigation for Parkinson\u2019s disease treatment","volume":"321","author":"Lin","year":"2020","journal-title":"J Control Release"},{"key":"R66-20260426","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2016.05.052","article-title":"Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson\u2019s disease mouse model","volume":"235","author":"Lin","year":"2016","journal-title":"J Control Release"},{"key":"R67-20260426","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.brs.2019.04.011","article-title":"Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington\u2019s disease mouse model","volume":"12","author":"Lin","year":"2019","journal-title":"Brain Stimul"},{"key":"R68-20260426","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.4103\/NRR.NRR-D-23-01470","article-title":"Isoform- and cell-state-specific APOE homeostasis and function","volume":"19","author":"Lindner","year":"2024","journal-title":"Neural Regen Res"},{"key":"R69-20260426","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00249-019-01383-2","article-title":"Liposome production and concurrent loading of drug simulants by microfluidic hydrodynamic focusing","volume":"48","author":"Lin","year":"2019","journal-title":"Eur Biophys J"},{"key":"R70-20260426","first-page":"2363","article-title":"Effects of neural stem cell transplantation in different ways on neuroinflammation in amyotrophic lateral sclerosis","volume":"27","author":"Lin","year":"2023","journal-title":"Zhongguo Zuzhi Gongcheng Yanjiu"},{"key":"R71-20260426","doi-asserted-by":"crossref","first-page":"e2101701","DOI":"10.1002\/adma.202101701","article-title":"Sphingosine 1-phosphate liposomes for targeted nitric oxide delivery to mediate anticancer effects against brain glioma tumors","volume":"33","author":"Liu","year":"2021","journal-title":"Adv Mater"},{"key":"R72-20260426","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"R73-20260426","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"R74-20260426","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/1673-5374.375316","article-title":"Impact of apolipoprotein E isoforms on sporadic Alzheimer\u2019s disease: beyond the role of amyloid beta","volume":"19","author":"Lozupone","year":"2024","journal-title":"Neural Regen Res"},{"key":"R75-20260426","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm Res"},{"key":"R76-20260426","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2174\/138161211797440221","article-title":"The ABC of the blood-brain barrier -regulation of drug efflux pumps","volume":"17","author":"Mahringer","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R77-20260426","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1039\/D1BM01202A","article-title":"Liposomes loaded with polyphenol-rich grape pomace extracts protect from neurodegeneration in a rotenone-based in vitro model of Parkinson\u2019s disease","volume":"9","author":"Marino","year":"2021","journal-title":"Biomater Sci"},{"key":"R78-20260426","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2014.05.019","article-title":"Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson\u2019s disease","volume":"274","author":"Migliore","year":"2014","journal-title":"Neuroscience"},{"key":"R79-20260426","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.isci.2019.07.023","article-title":"Small molecule binding to Alzheimer risk factor CD33 promotes A\u03b2 phagocytosis","volume":"19","author":"Miles","year":"2019","journal-title":"iScience"},{"key":"R80-20260426","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2015.07.010","article-title":"Amyloid \u03b2-peptide insertion in liposomes containing GM1-cholesterol domains","volume":"208","author":"Nicastro","year":"2016","journal-title":"Biophys Chem"},{"key":"R81-20260426","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s43440-022-00412-w","article-title":"Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect","volume":"74","author":"Nodari","year":"2022","journal-title":"Pharmacol Rep"},{"key":"R82-20260426","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2009.08.012","article-title":"Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis","volume":"1296","author":"Ohnishi","year":"2009","journal-title":"Brain Res"},{"key":"R83-20260426","doi-asserted-by":"crossref","first-page":"e1002338","DOI":"10.1371\/journal.pgen.1002338","article-title":"Oxr1 is essential for protection against oxidative stress-induced neurodegeneration","volume":"7","author":"Oliver","year":"2011","journal-title":"PLoS Genet"},{"key":"R84-20260426","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules"},{"key":"R85-20260426","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 4","key":"R86-20260426","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"R87-20260426","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","article-title":"Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease","volume":"17","author":"Palanki","year":"2023","journal-title":"ACS Nano"},{"key":"R88-20260426","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/pharmaceutics14061283","article-title":"A historical review of brain drug delivery","volume":"14","author":"Pardridge","year":"2022","journal-title":"Pharmaceutics"},{"key":"R89-20260426","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"R90-20260426","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","article-title":"Efficacy of cholesterol nose-to-brain delivery for brain targeting in Huntington\u2019s disease","volume":"11","author":"Passoni","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"R91-20260426","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/pharmaceutics11090465","article-title":"Development and characterization of the solvent-assisted active loading technology (SALT) for liposomal loading of poorly water-soluble compounds","volume":"11","author":"Pauli","year":"2019","journal-title":"Pharmaceutics"},{"key":"R92-20260426","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R93-20260426","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","article-title":"A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson\u2019s disease","volume":"277","author":"Qu","year":"2018","journal-title":"J Control Release"},{"key":"R94-20260426","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jchromb.2016.06.008","article-title":"A study on characteristic of different sample pretreatment methods to evaluate the entrapment efficiency of liposomes","volume":"1028","author":"Ran","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R95-20260426","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/joim.13440","article-title":"The influence of the blood-brain barrier in the treatment of brain tumours","volume":"292","author":"Rathi","year":"2022","journal-title":"J Intern Med"},{"key":"R96-20260426","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ijms19020436","article-title":"When immune cells turn bad-tumor-associated microglia\/macrophages in glioma","volume":"19","author":"Roesch","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R97-20260426","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","article-title":"The Neuropathology of Huntington\u00b4s disease: classical findings, recent developments and correlation to functional neuroanatomy","volume":"217","author":"R\u00fcb","year":"2015","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"R98-20260426","doi-asserted-by":"crossref","first-page":"117861","DOI":"10.1016\/j.lfs.2020.117861","article-title":"Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer\u2019s disease model","volume":"255","author":"Saffari","year":"2020","journal-title":"Life Sci"},{"key":"R99-20260426","doi-asserted-by":"crossref","first-page":"102119","DOI":"10.1016\/j.nano.2019.102119","article-title":"Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington\u2019s disease gene expression following intranasal administration","volume":"24","author":"Sava","year":"2020","journal-title":"Nanomedicine"},{"key":"R100-20260426","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpneuro0289","article-title":"Epidemiology and molecular pathology of glioma","volume":"2","author":"Schwartzbaum","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R101-20260426","doi-asserted-by":"crossref","first-page":"e2304654","DOI":"10.1002\/adma.202304654","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson\u2019s disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv Mater"},{"key":"R102-20260426","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1523\/JNEUROSCI.4885-10.2011","article-title":"Taxol facilitates axon regeneration in the mature CNS","volume":"31","author":"Sengottuvel","year":"2011","journal-title":"J Neurosci"},{"key":"R103-20260426","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R104-20260426","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog Neurobiol"},{"key":"R105-20260426","doi-asserted-by":"crossref","first-page":"120574","DOI":"10.1016\/j.lfs.2022.120574","article-title":"Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate","volume":"300","author":"Sheikholeslami","year":"2022","journal-title":"Life Sci"},{"key":"R106-20260426","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1523\/JNEUROSCI.1327-16.2016","article-title":"Blocking the interaction between EphB2 and ADDLs by a small peptide rescues impaired synaptic plasticity and memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Shi","year":"2016","journal-title":"J Neurosci"},{"key":"R107-20260426","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","article-title":"Chronic neuropathologies of single and repetitive TBI: substrates of dementia?","volume":"9","author":"Smith","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R108-20260426","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/1673-5374.379041","article-title":"Advantages of nanocarriers for basic research in the field of traumatic brain injury","volume":"19","author":"Song","year":"2024","journal-title":"Neural Regen Res"},{"key":"R109-20260426","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2020.09.055","article-title":"Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment","volume":"329","author":"Sonju","year":"2021","journal-title":"J Control Release"},{"key":"R110-20260426","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1021\/acsnano.3c03390","article-title":"Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway inhibition of ischemic penumbra","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"key":"R111-20260426","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"R112-20260426","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","article-title":"Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation","volume":"75","author":"Szoka","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R113-20260426","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"R114-20260426","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"key":"R115-20260426","doi-asserted-by":"crossref","first-page":"105636","DOI":"10.1016\/j.phrs.2021.105636","article-title":"New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation","volume":"169","author":"Taleb","year":"2021","journal-title":"Pharmacol Res"},{"key":"R116-20260426","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/acs.molpharmaceut.8b01284","article-title":"Development of liposomal gemcitabine with high drug loading capacity","volume":"16","author":"Tamam","year":"2019","journal-title":"Mol Pharm"},{"key":"R117-20260426","first-page":"459","article-title":"Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states","volume":"16","author":"Tang","year":"2021","journal-title":"Asian J Pharm Sci"},{"key":"R118-20260426","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6609a1","article-title":"Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - United States, 2007 and 2013","volume":"66","author":"Taylor","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"R119-20260426","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","article-title":"Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain","volume":"14","author":"Teixeira","year":"2022","journal-title":"Pharmaceutics"},{"key":"R120-20260426","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.00017.2017","article-title":"The biology of regeneration failure and success after spinal cord injury","volume":"98","author":"Tran","year":"2018","journal-title":"Physiol Rev"},{"key":"R121-20260426","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2018.05.002","article-title":"Ten-year survival in glioblastoma. A systematic review","volume":"54","author":"Tykocki","year":"2018","journal-title":"J Clin Neurosci"},{"key":"R122-20260426","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"R123-20260426","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/1673-5374.344841","article-title":"Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer\u2019s disease","volume":"18","author":"Wang","year":"2023","journal-title":"Neural Regen Res"},{"key":"R124-20260426","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuropharm.2011.09.016","article-title":"\u0391-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates \u03b2-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation","volume":"62","author":"Wang","year":"2012","journal-title":"Neuropharmacology"},{"key":"R125-20260426","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/md21070410","article-title":"A comparative study about the neuroprotective effects of DHA-enriched phosphatidylserine and EPA-enriched phosphatidylserine against oxidative damage in primary hippocampal neurons","volume":"21","author":"Wang","year":"2023","journal-title":"Mar Drugs"},{"key":"R126-20260426","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2017.03.010","article-title":"A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer","volume":"252","author":"Wehbe","year":"2017","journal-title":"J Control Release"},{"key":"R127-20260426","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jconrel.2020.01.012","article-title":"Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo","volume":"319","author":"Wei","year":"2020","journal-title":"J Control Release"},{"key":"R128-20260426","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neurobiolaging.2003.12.005","article-title":"Hippocampal neurons in pre-clinical Alzheimer\u2019s disease","volume":"25","author":"West","year":"2004","journal-title":"Neurobiol Aging"},{"key":"R129-20260426","doi-asserted-by":"crossref","first-page":"123106","DOI":"10.1016\/j.cej.2019.123106","article-title":"Supercritical fluid methods: an alternative to conventional methods to prepare liposomes","volume":"383","author":"William","year":"2020","journal-title":"Chem Eng J"},{"key":"R130-20260426","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"R131-20260426","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2710.2009.01128.x","article-title":"Pharmacokinetics and its relation to toxicity of pegylated-liposomal doxorubicin in Chinese patients with breast tumours","volume":"35","author":"Xu","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"R132-20260426","first-page":"1763","article-title":"Sphingosine 1-phosphate receptor 1 regulates blood-brain barrier permeability in epileptic mice","volume":"18","author":"Yang","year":"2023","journal-title":"Neural Regen Res"},{"key":"R133-20260426","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"R134-20260426","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41420-021-00639-1","article-title":"Transferrin-Pep63-liposomes accelerate the clearance of A\u03b2 and rescue impaired synaptic plasticity in early Alzheimer\u2019s disease models","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Death Discov"},{"key":"R135-20260426","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C9TB02470K","article-title":"Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications","volume":"8","author":"Yuba","year":"2020","journal-title":"J Mater Chem B"},{"key":"R136-20260426","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/1541-4337.12701","article-title":"Microstructures of encapsulates and their relations with encapsulation efficiency and controlled release of bioactive constituents: a review","volume":"20","author":"Yun","year":"2021","journal-title":"Comprehensive reviews in food science and food safety"},{"key":"R137-20260426","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-0716-2954-3_4","article-title":"Thin-film hydration followed by extrusion method for liposome preparation","volume":"2622","author":"Zhang","year":"2023","journal-title":"Methods Mol Biol"},{"key":"R138-20260426","first-page":"3177","article-title":"Delivery of pOXR1 through an injectable liposomal nanoparticle enhances spinal cord injury regeneration by alleviating oxidative stress","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioact Mater"},{"key":"R139-20260426","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chemphyslip.2003.09.013","article-title":"Determination of liposomal encapsulation efficiency using proton NMR spectroscopy","volume":"127","author":"Zhang","year":"2004","journal-title":"Chem Phys Lipids"},{"key":"R140-20260426","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","article-title":"Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity","volume":"222","author":"Zhao","year":"2016","journal-title":"J Control Release"},{"key":"R141-20260426","doi-asserted-by":"crossref","first-page":"2100722","DOI":"10.1002\/adfm.202100722","article-title":"Biomimetic nanoparticles as a theranostic tool for traumatic brain injury","volume":"31","author":"Zinger","year":"2021","journal-title":"Adv Funct Mater"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:14Z","timestamp":1786647254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":141,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-24-00048","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"2024-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}